Obsessive-compulsive disorder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1) Patients meets the diagnostic criteria for obsessive-compulsive disorder by the Mini-International Neuropsychiatric Interview (M.I.N.I.) meets with a total Y-BOCS score of 14 or more; 2) Those who have completed the 12-week waiting period in the previous randamized controlled trial (Study No. G2019017); 3) The age at the time of obtaining consent is between 15 and 60; 4) A person who intends to participate voluntarily and agrees to the research content after explaining the research content; 5) Ordinary treatment is given, and no new initiation or additional modification of drug therapy is planned during the study period; 6) Personal computer, tablet, smartphone, or other computer device capable of communication, or the guardian of a subject who is less than an adult owns the above device, and the subject himself or herself substantially uses it on a daily basis; 7) Have an Internet communication environment and have skills (send mail, open files, receive mail and read); 8) Has not received any cognitive-behavioral therapy, including exposure-response interference, for the last 2 years.
Exclusion criteria
Exclusion criteria: Exclusion criteria: 1) Organic disorders of the brain (including dementia), psychotic disorders, bipolar disorders, serious psychiatric disorders such as drug dependence, etc. are complicated, and cognitive-behavioral therapy is expected to be interrupted due to deterioration of these symptoms; 2) The cognitive-behavioral therapy is expected to be interrupted due to the imminent risk of suicide; 3) Cognitive behavioral therapy is expected to be interrupted due to repeated antisocial behavior; 4) Cognitive-behavioral therapy is expected to be discontinued due to severe progressive physical illness; 5) Due to severe stress reaction and dissociation symptoms due to acute stress disorder and post-traumatic stress disorder, it is difficult to expose to feared subjects; 6) There are significant problems due to attention deficit and hyperactivity disorderand autism spectrum disorder, and it is predicted that it will be difficult to receive stable treatment in the study conducted in this clinical study; 7) Those who reject the ERP; 8) Any other person who is judged by the investigator or the therapist to be unsuitable for the safe conduct of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessments of severity by using Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) will be performed at baseline and at the end of the intervention (12 weeks after the beginning of the intervention). | — |
Secondary
| Measure | Time frame |
|---|---|
| Obsessive-Compulsive Inventory, Working Alliance Inventory-Short From, EuroQol 5 Divison, Patient Health Questionnaire-9, Generalized Anxiety Disorder -7 at baseline and at the end of the intervention (12 weeks after the beginning of the intervention). | — |
Countries
Japan
Contacts
Chiba University Research Center for Child Mental Development